Preliminary Report of Intraovarian Injections of Autologous Platelet-Rich Plasma in Extremely Poor Prognosis Patients with Only Oocyte Donation as Alternative: A Prospective Cohort Study

    January 2022 in “ Human Reproduction Open
    David H. Barad, David F. Albertini, Emanuela Molinari, Norbert Gleicher
    New to Platelet-Rich Plasma? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study found no clinically significant effects of intraovarian injection of platelet-rich plasma on ovarian function over one year in patients with extremely low functional ovarian reserve.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results